Abbott Laboratories ABT has been delivering consistent organic growth in the Established Pharmaceuticals Division (EPD) and Diabetes segments. However, the soft neuromodulation business is a ...

Abbott's Neuromodulation group has created an app called the NeuroSphere Virtual Clinic, which allows patients with chronic pain who use spinal cord or dorsal root ganglion stimulators to have ...

Abbott neuromodulation medical director Allen Burton said: "Research shows treating CRPS with targeted DRG neurostimulation results in significantly better outcomes in terms of pain relief and ...

Abbott ABT and Medtronic MDT, two leading giants in the global medical device space, ... Neuromodulation also advanced 10%, led by next-generation systems like Inceptiv SCS and BrainSense DBS.

Abbott’s neuromodulation medical director says the company’s spinal cord stimulator, which won gold at the 2025 Edison Awards, is small but mighty. By Elliott Davis Jr. | May 27, 2025.

The goal of the study, Abbott's vice president of neuromodulation, Pedro Malha, said in the release, "is to develop the clinical evidence necessary to determine whether DBS is a safe and effective ...

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management ...

Abbott Laboratories ABT has been delivering consistent organic growth in the Established Pharmaceuticals Division (EPD) and Diabetes segments. However, the soft neuromodulation business is a ...